Astoriom

About Astoriom

At Astoriom, we are the global quality expert in safeguarding R&D samples.
For over 30 years, our customers have trusted us to secure, protect and preserve their scientific and consumer R&D product samples. We offer a comprehensive portfolio of sample stability storage, biorepository storage, disaster protection & recovery, and sample storage equipment & validation se...

  • Country/Region:
    United States
  • On CPHI since:
    2025
  • Employees:
    50 - 99
Company types
Contract Service
Other
Contact info

Products from Astoriom (2)

  • Biorepository Services

    Product Biorepository Services

    Astoriom is recognized for having the industry’s broadest portfolio of sample storage temperatures. From ambient to ultra-low temperature (ULT), cryogenic storage and reach-in to walk-in storage units, we ensure safe biological sample storage with advanced facilities designed for optimal preservation.
    ...
  • Stability Storage

    Product Stability Storage

    Astoriom ICH sample stability storage and assessment solutions provide our global R&D customers with an industry-leading comprehensive portfolio of ambient storage temperatures, humidity-controlled environment and ICH global climatic zone capabilities.

    ICH Q1A Sample Stability Storage qq...

Astoriom Resources (1)

  • Video Safeguarding Every R&D Sample - An Integrated Stability & Sustainability Outsourcing Model

    Ensuring the stability, integrity, and long-term sustainability of samples is critical for successful drug discovery and therapeutic development. This session introduces the Integrated Stability & Sustainability Outsourcing Model (ISSOM), a strategic approach that combines ICH-compliant stability storage, biorepository solutions, global logistics, disaster recovery, and regulatory-driven compliance to mitigate the risks of sample degradation and loss. Through real-world case studies, attendees will gain insights into how this model enhances sample preservation, operational efficiency, and regulatory adherence. Join Lori A. Ball, CEO of Astoriom, to explore how this model can drive scientific innovation and accelerate breakthroughs in drug development and personalized medicine.